Condensed Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 5,717	$ 3,233	$ 13,795	$ 5,212
General and administrative	3,209	2,507	6,785	4,425
Total operating expenses	8,926	5,740	20,580	9,637
Loss from operations	(8,926)	(5,740)	(20,580)	(9,637)
Other income (expenses):
Other income		500		500
Interest income (expense), net	2	(1)	3	(2)
Net loss	$ (8,924)	$ (5,241)	$ (20,577)	$ (9,139)
Per share information:
Net loss per share of common stock, Basic	$ (0.74)	$ (0.46)	$ (1.70)	$ (0.83)
Net loss per share of common stock, Diluted	$ (0.74)	$ (0.46)	$ (1.70)	$ (0.83)
Weighted-average common shares outstanding, Basic	12,127,385	11,456,991	12,125,156	11,051,185
Weighted-average common shares outstanding, Diluted	12,127,385	11,456,991	12,125,156	11,051,185